STERIS Other Non-Current Liabilities increased by 5.5% to $67.40M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 7.8%, from $73.13M to $67.40M. Over 4 years (FY 2021 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -8.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $86.04M | $83.59M | $74.76M | $75.58M | $73.08M | $75.90M | $72.75M | $76.14M | $76.60M | $76.55M | $78.39M | $71.55M | $72.37M | $74.15M | $73.13M | $61.90M | $63.60M | $63.90M | $67.40M |
| QoQ Change | — | -2.8% | -10.6% | +1.1% | -3.3% | +3.9% | -4.2% | +4.7% | +0.6% | -0.1% | +2.4% | -8.7% | +1.1% | +2.5% | -1.4% | -15.4% | +2.7% | +0.5% | +5.5% |
| YoY Change | — | — | — | — | -15.1% | -9.2% | -2.7% | +0.7% | +4.8% | +0.9% | +7.8% | -6.0% | -5.5% | -3.1% | -6.7% | -13.5% | -12.1% | -13.8% | -7.8% |